Topical Treatment with Diclofenac, Calcipotriol (Vitamin-D3 Analog) and Difluoromethylornithine (DFMO) Does Not Prevent Nonmelanoma Skin Cancer in Mice

Author： Pommergaard H. C.   Burcharth J.   Rosenberg J.   Raskov H.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.31, Iss.2, 2013-02, pp. : 92-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer

By              

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1199-1203

Spandidos Publications

Access to resources Recommend Favorite

Treatment Decisions for Non-Melanoma Skin Cancer (NMSC)

By  

Current Cancer Therapy Reviews, Vol. 12, Iss. 2, 2016-12 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Nonmelanoma skin cancer

By Nguyen Tri   Ho Diana  

Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. : 193-203

Springer Publishing Company

Access to resources Recommend Favorite

Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?

By Dagdemir Ayhan  

Supportive Care in Cancer, Vol. 12, Iss. 4, 2004-04 ,pp. : 263-267

Springer Publishing Company

Access to resources Recommend Favorite

Sunlight Vitamin D and Skin Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 1, 2013-01 ,pp. : 83-97

Bentham Science Publishers

Access to resources Recommend Favorite